Jianda Zhou1, Rui Liu1, Chengqun Luo1, Xiao Zhou2, Kun Xia3, Xiang Chen4, Ming Zhou5, Qiong Zou6, Peiguo Cao7, Ke Cao7. 1. Department of Plastic and Reconstructive Surgery; Third Xiangya Hospital; Central South University; Changsha City, Hunan, PR China. 2. Department of Oncoplastic and Reconstructive Surgery; The Affiliated Tumor Hospital of Xiangya Medical School; Changsha City, Hunan, PR China. 3. State Key Laboratory of Medical Genetics; Changsha City, Hunan, PR China. 4. Department of Dermatology; Xiangya Hospital; Changsha City, Hunan, PR China. 5. Cancer Research Institute; Key Laboratory of Carcinogenesis of Ministry of Health; Changsha City, Hunan, PR China. 6. Department of Pathology; Third Xiangya Hospital; Central South University; Changsha City, Hunan, PR China. 7. Department of Oncology; Third Xiangya Hospital; Central South University; Changsha City, Hunan, PR China.
Abstract
BACKGROUND: MicroRNA-20a (miR-20a) plays a key role in tumorigenesis and progression. But its function is reverse in different kinds of malignant tumor, and its role and mechanism in cutaneous squamous cell carcinoma (CSCC) remains unclear. OBJECT: To determine the miR-20a's roles in CSCC and confirm whether LIMK1 is a direct target gene of miR-20a. METHODS: First miR-20a and LIMK1 expression levels were detected in six pairs of CSCC tissues and corresponding normal skin by qRT-PCR. Then MTT assays and colony formation assays were performed to evaluate the impact of miR-20a on cell proliferation. In addition, scratch migration assays and transwell invasion assays were performed to check miR-20a's effect on cell metastasis. Since LIMK1 (LIM kinase-1) was predicted as a target gene of miR-20a, the changes of LIMK1 protein and mRNA were measured by western blot and qRT-RCR methods after miR-20a overexpression. Moreover the dual reporter gene assay was performed to confirm whether LIMK1 is a direct target gene of miR-20a. Finally LIMK1 mRNA and miR-20a in other 30 cases of CSCC pathological specimens were determined and a correlation analysis was evaluated. RESULTS: The miR-20a significantly low-expressed in CSCC tissues compared with that in matched normal tissues while LIMK1 has a relative higher expression. MiR-20a inhibited A431 and SCL-1 proliferation and metastasis. Both of LIMK1 protein and mRNA levels were downregulated after miR-20a overexpression. The dual reporter gene assays revealed that LIMK1 is a direct target gene of miR-20a. Furthermore, qRT-PCR results of LIMK1 mRNA and miR-20a in 30 cases of CSCC pathological specimens showed miR-20a is inversely correlated with LIMK1 expression. CONCLUSION: Our study demonstrated that miR-20a is involved in the tumor inhibition of CSCC by directly targeting LIMK1 gene. This finding provides potential novel strategies for therapeutic interventions of CSCC.
BACKGROUND:MicroRNA-20a (miR-20a) plays a key role in tumorigenesis and progression. But its function is reverse in different kinds of malignant tumor, and its role and mechanism in cutaneous squamous cell carcinoma (CSCC) remains unclear. OBJECT: To determine the miR-20a's roles in CSCC and confirm whether LIMK1 is a direct target gene of miR-20a. METHODS: First miR-20a and LIMK1 expression levels were detected in six pairs of CSCC tissues and corresponding normal skin by qRT-PCR. Then MTT assays and colony formation assays were performed to evaluate the impact of miR-20a on cell proliferation. In addition, scratch migration assays and transwell invasion assays were performed to check miR-20a's effect on cell metastasis. Since LIMK1 (LIM kinase-1) was predicted as a target gene of miR-20a, the changes of LIMK1 protein and mRNA were measured by western blot and qRT-RCR methods after miR-20a overexpression. Moreover the dual reporter gene assay was performed to confirm whether LIMK1 is a direct target gene of miR-20a. Finally LIMK1 mRNA and miR-20a in other 30 cases of CSCC pathological specimens were determined and a correlation analysis was evaluated. RESULTS: The miR-20a significantly low-expressed in CSCC tissues compared with that in matched normal tissues while LIMK1 has a relative higher expression. MiR-20a inhibited A431 and SCL-1 proliferation and metastasis. Both of LIMK1 protein and mRNA levels were downregulated after miR-20a overexpression. The dual reporter gene assays revealed that LIMK1 is a direct target gene of miR-20a. Furthermore, qRT-PCR results of LIMK1 mRNA and miR-20a in 30 cases of CSCC pathological specimens showed miR-20a is inversely correlated with LIMK1 expression. CONCLUSION: Our study demonstrated that miR-20a is involved in the tumor inhibition of CSCC by directly targeting LIMK1 gene. This finding provides potential novel strategies for therapeutic interventions of CSCC.
Authors: Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson Journal: Nature Date: 2005-01-30 Impact factor: 49.962
Authors: E A Nikitina; A V Medvedeva; Iu F Dolgaia; L I Korochkin; G V Pavlova; E V Savvateeva-Popova Journal: Zh Evol Biokhim Fiziol Date: 2012 Nov-Dec
Authors: Nils O Lindström; Carlos Neves; Rebecca McIntosh; Zosia Miedzybrodzka; Neil Vargesson; J Martin Collinson Journal: Gene Expr Patterns Date: 2010-12-16 Impact factor: 1.224
Authors: Junying Chen; Desheng Yao; Yue Li; Hong Chen; Chanjuan He; Nan Ding; Yan Lu; Tingyu Ou; Shan Zhao; Li Li; Fengyi Long Journal: Int J Mol Med Date: 2013-06-21 Impact factor: 4.101
Authors: Fengju Song; Abrar A Qureshi; Edward L Giovannucci; Charlie S Fuchs; Wendy Y Chen; Meir J Stampfer; Jiali Han Journal: PLoS Med Date: 2013-04-23 Impact factor: 11.069
Authors: Horacio Gonzalez; Carolina Lema; Robert A Kirken; Rosa A Maldonado; Armando Varela-Ramirez; Renato J Aguilera Journal: Clin Cancer Drugs Date: 2015
Authors: Anna-Maria Pehserl; Anna Lena Ress; Stefanie Stanzer; Margit Resel; Michael Karbiener; Elke Stadelmeyer; Verena Stiegelbauer; Armin Gerger; Christian Mayr; Marcel Scheideler; Georg C Hutterer; Thomas Bauernhofer; Tobias Kiesslich; Martin Pichler Journal: Int J Mol Sci Date: 2016-12-01 Impact factor: 5.923